192 related articles for article (PubMed ID: 33129329)
1. Characterization of WWOX expression and function in canine mast cell tumors and malignant mast cell lines.
Makii R; Cook H; Louke D; Breitbach J; Jennings R; Premanandan C; Green EM; Fenger JM
BMC Vet Res; 2020 Oct; 16(1):415. PubMed ID: 33129329
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of miR-9 in mast cells is associated with invasive behavior and spontaneous metastasis.
Fenger JM; Bear MD; Volinia S; Lin TY; Harrington BK; London CA; Kisseberth WC
BMC Cancer; 2014 Feb; 14():84. PubMed ID: 24517413
[TBL] [Abstract][Full Text] [Related]
3. Canine mast cell tumors express stem cell factor receptor.
Reguera MJ; Rabanal RM; Puigdemont A; Ferrer L
Am J Dermatopathol; 2000 Feb; 22(1):49-54. PubMed ID: 10698217
[TBL] [Abstract][Full Text] [Related]
4. In situ c-KIT mRNA quantification of canine cutaneous mast cell tumours and its relationship to prognostic factors.
Seung BJ; Cho SH; Kim SH; Bae MK; Lim HY; Sur JH
Vet Comp Oncol; 2021 Mar; 19(1):132-139. PubMed ID: 32926564
[TBL] [Abstract][Full Text] [Related]
5. HSP32 and HSP90 Immunoexpression, in Relation to Kit Pattern, Grading, and Mitotic Count in Canine Cutaneous Mast Cell Tumors.
Romanucci M; Massimini M; Ciccarelli A; Malatesta D; Bongiovanni L; Gasbarre A; Della Salda L
Vet Pathol; 2017 Mar; 54(2):222-225. PubMed ID: 27627984
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of exon 11 internal tandem duplications in the C-KIT proto-oncogene in Australian canine mast cell tumours.
Tamlin VS; Kessell AE; Mccoy RJ; Dobson EC; Smith TS; Hebart M; Brown L; Mitrovic D; Peaston AE
Aust Vet J; 2017 Oct; 95(10):386-391. PubMed ID: 28948627
[TBL] [Abstract][Full Text] [Related]
7. TSLC1 tumour-suppressor gene expression in canine mast cell tumours.
Taylor F; Murphy S; Hoather T; Dobson J; Scase T
Vet Comp Oncol; 2010 Dec; 8(4):263-72. PubMed ID: 21062408
[TBL] [Abstract][Full Text] [Related]
8. WWOX sensitises ovarian cancer cells to paclitaxel via modulation of the ER stress response.
Janczar S; Nautiyal J; Xiao Y; Curry E; Sun M; Zanini E; Paige AJ; Gabra H
Cell Death Dis; 2017 Jul; 8(7):e2955. PubMed ID: 28749468
[TBL] [Abstract][Full Text] [Related]
9. WWOX inhibits the invasion of lung cancer cells by downregulating RUNX2.
Zheng QW; Zhou YL; You QJ; Shou F; Pang QF; Chen JL
Cancer Gene Ther; 2016 Dec; 23(12):433-438. PubMed ID: 27834355
[TBL] [Abstract][Full Text] [Related]
10. Identification of two molecular subtypes in canine mast cell tumours through gene expression profiling.
Pulz LH; Barra CN; Alexandre PA; Huete GC; Cadrobbi KG; Nishiya AT; de Freitas SH; Fukumasu H; Strefezzi RF
PLoS One; 2019; 14(6):e0217343. PubMed ID: 31216299
[TBL] [Abstract][Full Text] [Related]
11. Canine and Feline Cutaneous Mast Cell Tumor: A Comprehensive Review of Treatments and Outcomes.
Oliveira MT; Campos M; Lamego L; Magalhães D; Menezes R; Oliveira R; Patanita F; Ferreira DA
Top Companion Anim Med; 2020 Nov; 41():100472. PubMed ID: 32891740
[TBL] [Abstract][Full Text] [Related]
12. VOPP1 promotes breast tumorigenesis by interacting with the tumor suppressor WWOX.
Bonin F; Taouis K; Azorin P; Petitalot A; Tariq Z; Nola S; Bouteille N; Tury S; Vacher S; Bièche I; Rais KA; Pierron G; Fuhrmann L; Vincent-Salomon A; Formstecher E; Camonis J; Lidereau R; Lallemand F; Driouch K
BMC Biol; 2018 Oct; 16(1):109. PubMed ID: 30285739
[TBL] [Abstract][Full Text] [Related]
13. Ki67/KIT double immunohistochemical staining in cutaneous mast cell tumors from Boxer dogs.
Fonseca-Alves CE; Bento DD; Torres-Neto R; Werner J; Kitchell B; Laufer-Amorim R
Res Vet Sci; 2015 Oct; 102():122-6. PubMed ID: 26412531
[TBL] [Abstract][Full Text] [Related]
14. Expression of B Cell-Specific Moloney Murine Leukemia Virus Integration Site 1 (BMI-1) and WW Domain-Containing Oxidoreductase (WWOX) in Liver Cancer Tissue and Normal Liver Tissue.
Yu J; Hu M; Chen W; Wen Z
Med Sci Monit; 2018 Sep; 24():6673-6679. PubMed ID: 30242144
[TBL] [Abstract][Full Text] [Related]
15. Carboxypeptidase A3 expression in canine mast cell tumors and tissue-resident mast cells.
Hämäläinen S; Kareinen L; Sukura A; Kareinen I
Vet Pathol; 2022 Mar; 59(2):236-243. PubMed ID: 34894899
[TBL] [Abstract][Full Text] [Related]
16. CD25 is expressed by canine cutaneous mast cell tumors but not by cutaneous connective tissue mast cells.
Meyer A; Gruber AD; Klopfleisch R
Vet Pathol; 2012 Nov; 49(6):988-97. PubMed ID: 22446323
[TBL] [Abstract][Full Text] [Related]
17. The phosphoinositide 3-kinase pathway is crucial for the growth of canine mast cell tumors.
Amagai Y; Tanaka A; Matsuda A; Oida K; Jung K; Matsuda H
J Vet Med Sci; 2013; 75(6):791-4. PubMed ID: 23328607
[TBL] [Abstract][Full Text] [Related]
18. Effects of ibrutinib on proliferation and histamine release in canine neoplastic mast cells.
Gamperl S; Stefanzl G; Peter B; Smiljkovic D; Bauer K; Willmann M; Valent P; Hadzijusufovic E
Vet Comp Oncol; 2019 Dec; 17(4):553-561. PubMed ID: 31286638
[TBL] [Abstract][Full Text] [Related]
19. Expression of Ki67, BCL-2, and COX-2 in canine cutaneous mast cell tumors: association with grading and prognosis.
Vascellari M; Giantin M; Capello K; Carminato A; Morello EM; Vercelli A; Granato A; Buracco P; Dacasto M; Mutinelli F
Vet Pathol; 2013 Jan; 50(1):110-21. PubMed ID: 22673539
[TBL] [Abstract][Full Text] [Related]
20. Somatic loss of WWOX is associated with TP53 perturbation in basal-like breast cancer.
Abdeen SK; Ben-David U; Shweiki A; Maly B; Aqeilan RI
Cell Death Dis; 2018 Aug; 9(8):832. PubMed ID: 30082886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
